← Back to headlines
CVS Health Reintroduces Coverage for Lilly’s Zepbound
CVS Health has reinstated coverage for Eli Lilly's weight-loss drug Zepbound.
28 May, 11:35 — 28 May, 11:35
Sources
Showing 1 of 1 sources
Related Stories
Bank of Korea Raises Interest Rate to 3 Percent Amid Growth Upgrade
15m ago
Nvidia in Talks to Acquire AI Platform Hugging Face for Over $13 Billion
26m ago
Meta Reaches Up to $18 Billion Settlement in Teen Social Media Addiction Lawsuit
30m ago
Mesoblast Reports Strong Revenue Growth Amid Commercial Transition
39m ago